Resistance of Human Cytomegalovirus to the Benzimidazole l-Ribonucleoside Maribavir Maps to UL27

1-(β-d-Ribofuranosyl)-2,5,6-trichlorobenzimidazole (TCRB) and its 2-bromo analog, BDCRB, are potent and selective inhibitors of human cytomegalovirus (HCMV) DNA processing and packaging. Since they are readily metabolized in vivo, analogs were synthesized to improve biostability. One of these, 1-(β-...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Komazin, Gloria, Ptak, Roger G., Emmer, Brian T., Townsend, Leroy B., Drach, John C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC229258/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14557635/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.21.11499-11506.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!